It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) is the gold standard method for SARS-CoV-2 detection, and several qRT-PCR kits have been established targeting different genes of the virus. Due to the high mutation rate of these genes, false negative results arise thus complicating the interpretation of the diagnosis and increasing the need of alternative targets. In this study, an alternative approach for the detection of SARS-CoV-2 viral RNA targeting the membrane (M) gene of the virus using qRT-PCR was described. Performance evaluation of this newly developed in-house assay against commercial qRT-PCR kits was done using clinical oropharyngeal specimens of COVID-19 positive patients. The limit of detection was determined using successive dilutions of known copies of SARS-CoV-2 pseudovirus. The M gene based assay was able to detect a minimum of 100 copies of virus/mL indicating its capacity to detect low viral load. The assay showed comparable accuracy, sensitivity and specificity with commercially available kits while detecting all the variants efficiently. The study concluded that the in-house M gene based assay might be an effective alternative for the currently available commercial qRT-PCR kits.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Bangladesh Council of Scientific and Industrial Research (BCSIR), Dhaka, Bangladesh (GRID:grid.466521.2) (ISNI:0000 0001 2034 6517)
2 DNA Solution Ltd., Dhaka, Bangladesh (GRID:grid.466521.2)
3 DNA Solution Ltd., Dhaka, Bangladesh (GRID:grid.466521.2); University of Dhaka, Dhaka, Bangladesh (GRID:grid.8198.8) (ISNI:0000 0001 1498 6059)
4 University of Dhaka, Dhaka, Bangladesh (GRID:grid.8198.8) (ISNI:0000 0001 1498 6059)
5 Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh (GRID:grid.411509.8) (ISNI:0000 0001 2034 9320)
6 Bangladesh Council of Scientific and Industrial Research (BCSIR), Dhaka, Bangladesh (GRID:grid.466521.2) (ISNI:0000 0001 2034 6517); University of Dhaka, Dhaka, Bangladesh (GRID:grid.8198.8) (ISNI:0000 0001 1498 6059)